The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection

Clinical trial NCT06065176 · COMPLETED

Trial details

NCT number: NCT06065176
Sponsor: Sarang K. Yoon, DO, MOH
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

COVID-19 Vaccine-Preventable Diseases SARS CoV 2 Infection Upper Respiratory Tract Infection Upper Respiratory Disease

Start date: 2023-11-22
Primary completion: 2024-09-02
Enrollment: 1188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.